What AllDone Treats: Main Uses and Benefits

AllDone is generally used for the short-term symptomatic relief of symptoms related to inflammatory or irritative states. This medication is commonly applied in settings marked by temporary physiological imbalance.

---

Symptom Relief and Clinical Context

The medication is commonly used to help address symptom clusters that may become intense or disruptive, such as the combination of acute pain, inflammation, and fever. It is relevant for managing discomfort associated with musculoskeletal conditions—like acute tendinitis and painful, episodic flare-ups of osteoarthritis—and is relevant for easing specific painful scenarios, including primary dysmenorrhoea (menstrual cramps) and pain following minor dental surgery.

This supportive relief may assist with maintaining a sense of stability during periods of heightened symptoms, contributing to improved comfort when symptoms interfere with routine activities.

“Applied in situations where additional symptomatic support is needed, AllDone helps to ease the overall burden of acute pain and inflammation.”

Quick Fact: Relief for Acute Discomfort
Primary Focus	Mild to moderate pain and inflammation
Key Scenarios	Post-traumatic, cyclical (menstrual), and dental pain
Patient Benefit	Supports maintenance of functional stability

Regulatory References

1. European Medicines Agency (EMA) documentation

Official Eligibility Profile: Who Can and Cannot Use AllDone

Regulatory agencies strictly define the patient populations eligible to use AllDone based on established safety and efficacy data. This information is non-advisory and solely descriptive of official labeling.

Contraindications and Restrictions

Category	Regulatory Status & Patient Group
Absolute Contraindication	Patients with known hypersensitivity to the active substance or excipients, or those with severe decompensated hepatic failure are prohibited from using AllDone.
Age-Related	Use in pediatric patients (typically under 12 or 18 years) is often not established and generally not recommended due to insufficient data. Older adults may require a lower starting dose or special caution.
Physiological Status	Use during pregnancy or breastfeeding is generally not recommended due to documented risks or insufficient safety data, and must be weighed carefully against therapeutic needs.
Organ Function	Patients with moderate hepatic or renal impairment may require mandatory dose adjustments or restricted use based on the official product label.

Eligibility is limited to adult patients without these specific exclusionary factors. The use of AllDone is contingent upon meeting these official criteria.

Interactions with other medicines and products

AllDone, which contains the active substance Nimesulide, has documented interaction patterns based on regulatory prescribing information. The official profile dictates restrictions concerning both pharmacodynamic and pharmacokinetic mechanisms.

---

Contraindications and Restrictions

Co-administration is formally contraindicated with other Nimesulide-containing products and other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including acetylsalicylic acid. This prohibition is due to the established additive risk of gastrointestinal ulceration, bleeding, and potential renal toxicity.

---

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Substance/Class	Official Interaction Description
Anticoagulants (e.g., Warfarin), Antiplatelet agents, SSRIs	Increased anticoagulant effect and elevated risk of gastrointestinal bleeding. (Pharmacodynamic)
Lithium and Phenytoin	May result in increased plasma concentrations (exposure) of the co-administered drug. (Pharmacokinetic)
Diuretics, ACE Inhibitors, ARBs	Potential for reduced diuretic effect and deteriorated renal function, especially in elderly patients. (Pharmacodynamic)
Methotrexate	Co-administration may increase plasma concentrations and exposure of Methotrexate. (Pharmacokinetic)

Administration with food is noted to reduce the rate of Nimesulide absorption, although the total systemic exposure remains unchanged. The enhanced risk of interaction with diuretics and antihypertensives is specifically noted to be more clinically significant in the elderly population in regulatory documentation.

AllDone is a fixed-dose combination product whose mechanism is mediated by five distinct components acting on multiple biological targets across several systems.

Aceclofenac and Paracetamol modulate eicosanoid synthesis. Aceclofenac is a nonsteroidal compound that functions as an inhibitor of cyclooxygenase (COX) enzymes, subsequently reducing the biosynthesis of prostaglandins within peripheral tissues and the central nervous system. Paracetamol primarily inhibits central prostaglandin synthesis.

Cetirizine is a peripheral histamine H1 receptor antagonist. It competitively binds to and blocks the H1 receptor, preventing the endogenous agonist, histamine, from initiating intracellular signaling. This action modulates histamine-mediated downstream cascades in the gastrointestinal tract, blood vessels, and respiratory tract.

Phenylephrine acts as an alpha1-adrenergic receptor agonist. It selectively binds to alpha1 receptors on vascular smooth muscle, activating the Gq protein-coupled signaling pathway. This activation triggers an increase in intracellular calcium, promoting smooth muscle contraction and resulting in systemic vasoconstriction, particularly within the nasal mucosa.

Caffeine, a methylxanthine, acts as a non-selective antagonist of adenosine receptors and an inhibitor of phosphodiesterase enzymes. Antagonism of adenosine receptors leads to increased neuronal excitability and systemic central nervous system stimulation.

How AllDone is Used

AllDone (Nimesulide) is intended strictly for oral administration in its systemic forms (tablets, granules, and suspension). The usage parameters are designed to ensure consistent dosing for the shortest possible time.

Standard Dosing and Administration

The prescribing principle requires the use of the minimum effective dose for the shortest necessary duration.

Usage Parameter	Instruction
Standard Single Dose (Adult)	100 mg Nimesulide
Dosing Frequency	Twice a day (bid)
Maximum Daily Dose	200 mg
Timing of Intake	Must be taken after a meal

Granules for oral suspension must be fully dissolved in a small amount of water immediately before administration. The medicine is primarily intended for use as a second-line treatment, meaning it is prescribed when other options have been considered.

Treatment Duration and Specific Populations

Standard limits apply to how long AllDone may be used, regardless of the patient's condition.

Use Constraint	Instruction
Maximum Treatment Duration	15 days total duration for any treatment course
Older Adults	No reduction in daily dosage is typically necessary
Mild to Moderate Impairment	No dose adjustment needed for those with mild to moderate renal impairment (Creatinine clearance 30-80 ml/min)

These instructions establish the boundaries for the systemic use of Nimesulide, strictly focusing on the how-to-use protocol.

Research evidence / Overview of studies for AllDone

---

Evidence for Short-Term Relief of Acute Pain

The research base for AllDone's active ingredient, Nimesulide, primarily consists of numerous short-term Randomized Controlled Trials (RCTs) and systematic reviews. These trials were applied in research exploring how symptoms change over time by enrolling adults and adolescents (generally 12 years and older) experiencing acute, or temporary, pain. Researchers focused on outcomes related to physical discomfort by measuring changes in pain intensity using standardized scales, and also tracked the time elapsed before patients reported a change in their symptoms.

Findings describe the measured reductions in pain intensity scores in the group receiving the medication compared to the placebo group. Furthermore, research highlights changes measured during the study period. Studies reported similar measurement patterns to those observed for other established NSAIDs included as active comparators.

---

Evidence for Symptomatic Relief of Primary Dysmenorrhoea

AllDone was evaluated in specific clinical trials focusing on conditions characterized by fluctuating or episodic manifestations, such as primary dysmenorrhoea (menstrual cramps). The study outcomes examined included outcomes describing episodic or acute changes in pain severity and monitoring the patient's need for supplementary or rescue pain medication. The research describes measured changes in pain severity and patterns related to the reported use of additional pain relief when compared to placebo in these trials.

What remains uncertain are the measured outcomes of using the medication before the onset of symptoms, as the research primarily examines temporary physiological imbalance after pain has begun. Long-term effects are not fully established, as the follow-up durations were limited to a single symptomatic episode, offering limited information for long-term outcomes across multiple cycles.

---

Key Limitations and Uncertainties in the Research Record

The research base has several acknowledged limitations. Long-term effects are not fully established, and there is limited information for long-term outcomes because the studies were not designed to monitor patients beyond the acute phase. The maximum duration of a treatment course for the approved indications is 15 days.

Furthermore, data for certain patient groups, such as those with complex underlying comorbid conditions or in the older adult population, are not well-established in the main body of the research. Subgroup findings are uncertain for populations not well-represented in the primary trials. Ultimately, evidence contributes to understanding symptom patterns for acute episodes, but certainty remains low regarding outcomes of extended use.

Key Studies & References

1. Nimesulide for painful osteoarthritis (Review of short-term studies)

Common questions about AllDone (FAQ)

---

Q: How long does the effect of a single dose of AllDone typically last?

A: The official documentation describes a dosing regimen of twice daily, which suggests a 12-hour interval between doses. According to official pharmacokinetic information, the measured elimination half-life of the active substance, Nimesulide, generally ranges from about 2 to 5 hours after it is taken orally.

---

Q: Can AllDone affect how birth control works?

A: Official prescribing documents do not list oral contraceptives as a formal pharmacokinetic interaction with this medicine. However, due to the warning regarding potential serious liver reactions, official caution is noted when using the medicine with other substances that may affect liver function.

---

Q: Does AllDone interact with common over-the-counter pain relievers?

A: Regulatory documents formally contraindicate co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including acetylsalicylic acid. Furthermore, official labels advise avoiding other analgesics, such as paracetamol, as they may potentially increase the risk of hepatic reactions.

---

Q: Is AllDone known to cause weight gain or loss?

A: The official safety profile lists Oedema (swelling or fluid retention) as an uncommon adverse reaction that occurs in some patients. However, general weight gain or weight loss is not explicitly listed as a classified adverse reaction in the frequency tables provided in regulatory documents.

---

Q: Can AllDone make you feel dizzy or light-headed?

A: Yes, the official documentation lists Dizziness as an uncommon adverse reaction (affecting 1 to 10 in 1,000 users). Vertigo is also listed as a very rare effect. These symptoms are cited as a reason to follow the official caution regarding activities like driving or operating machinery.

---

Q: What happens if I take too much AllDone, based on the information provided?

A: Reported symptoms of taking too much medicine include general effects such as fatigue, drowsiness, nausea, vomiting, and abdominal pain. Overdose may also be associated with serious hepatic reactions (severe liver injury), which regulatory standards mandate be managed by immediate professional attention.

---

Q: How long after stopping AllDone is the medicine typically cleared from the body?

A: The active ingredient has a plasma elimination half-life that typically varies between approximately 2 to 5 hours. The body eliminates the drug by metabolic transformation into a primary, less active compound.

---

Q: Is AllDone an antibiotic or is it for pain?

A: AllDone is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not an antibiotic. Its purpose, according to official documents, is to provide analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties.

---

Q: Is AllDone available over the counter, or is it prescription-only?

A: In countries where it is authorized, this medicine is designated as a prescription-only medicine. Regulatory status defines its use as a second-line treatment restricted to a maximum of 15 days under the supervision of a healthcare professional.

---

Q: What are the most common things people misunderstand about how AllDone is used?

A: A key constraint noted in official documents is the maximum total duration of use. The prescribing principle requires the use of the minimum effective dose for the shortest necessary duration, and the total course must not exceed 15 days.

---

Q: Can AllDone be taken by people who are vegetarian or vegan?

A: Official documentation confirms the product contains various excipients (inactive ingredients). The suitability for vegetarian or vegan diets depends on the specific excipient list. This information is detailed in the full product package leaflet and can be clarified by a pharmacist.

---

Q: Does AllDone contain any ingredients that might be considered allergens?

A: Yes, the medicine is strictly contraindicated (prohibited) for use in patients with a known history of hypersensitivity to the active substance (Nimesulide) or to any of the excipients (inactive ingredients) found in the product's formulation.

---

Q: How does AllDone compare to similar medicines that treat the same condition?

A: Official documentation identifies the drug by its chemical structure as a sulfonanilide derivative and functionally classifies it as a Cyclooxygenase-2 (COX-2) selective inhibitor. This information defines its pharmacological profile relative to other Nonsteroidal Anti-inflammatory Drugs.

---

Q: I heard AllDone is related to Drug X. How are they different?

A: AllDone is described as a single-component product containing only the active substance, Nimesulide. If another medicine is a fixed-dose combination product containing multiple active pharmaceutical ingredients, the primary difference lies in its complete composition.

---

Q: If I miss a dose of AllDone, what does the official information say I should do?

A: Official guidance describes that if a dose is forgotten, the next scheduled dose should be taken at the usual time. The procedure stated is to not compensate for the missed dose by taking a double dose.

---

Q: Are there any vitamins or supplements that are officially listed as interacting with AllDone?

A: Official interaction tables primarily list prescription drug classes. However, the label warns against concomitant exposure to potentially hepatotoxic substances and those that influence the CYP450 enzyme system, which includes certain herbal supplements like St. John’s Wort.

---

Q: Can AllDone be used by children, and if so, what are the age restrictions?

A: The systemic use of the medicine is officially contraindicated (prohibited) for children younger than 12 years of age. For adolescents between 12 and 18 years, regulatory documents note that no specific dose adjustment is typically necessary.

---

Q: Is AllDone known to cause issues with driving or operating machinery?

A: No studies on the effect on the ability to drive have been performed. However, due to documented adverse reactions like dizziness or somnolence (drowsiness), the official label notes that patients who experience these symptoms are cautioned against driving or operating machinery.

---

Q: What kind of research has been done on the long-term use of AllDone?

A: The primary research base consists of short-term clinical trials for acute symptoms. The documentation specifically notes that long-term effects are not fully established and its use is restricted to a maximum treatment course of 15 days.

---

Q: Is there a generic version of AllDone available?

A: The active substance is known as Nimesulide. In authorized countries, the medicine is available in various brand names and also in generic formulations under the name Nimesulide.

---

Q: Why do some people experience trouble sleeping after taking AllDone?

A: The official safety profile lists Anxiety and Nervousness as rare psychiatric disorders, and Nightmare as a rare adverse reaction. These are examples of adverse reactions that may be associated with difficulty in sleeping.

---

Q: Is it possible to become physically dependent on AllDone, based on official descriptions?

A: AllDone is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is not classified as a narcotic or controlled substance. While the official label lists alcoholism and drug addiction as patient contraindications, the medicine itself is not associated with physical dependence.

---

Q: Are there any dietary restrictions mentioned in the official paperwork for AllDone?

A: The official product information specifies that a condition of use is that the medicine is taken after a meal to help minimize potential gastrointestinal effects. Beyond this timing, official prescribing documents do not specify general dietary restrictions.

---

Q: Can AllDone interact with herbal teas or supplements like St. John's Wort?

A: The official label warns against concomitant exposure to substances that influence the CYP450 enzyme system in the liver. Certain herbal supplements, such as St. John’s Wort, are known to affect these enzymes, potentially altering the drug's exposure in the body.

---

Q: Does AllDone cause changes in mood or behavior?

A: The official safety profile lists several adverse reactions affecting the central nervous system. Specifically, Anxiety and Nervousness are documented as rare psychiatric disorders, and Somnolence (drowsiness) is listed as a very rare nervous system disorder.

How to Store and Dispose of AllDone?

All storage and disposal procedures for AllDone must adhere strictly to the official regulatory labeling.

---

Storage Requirements

The medication must be stored at room temperature, generally defined as below 30 C. To protect its stability, AllDone must be kept in the original container and shielded from light and moisture. It is a mandatory requirement to store the product out of the sight and reach of children to prevent accidental ingestion. The product must not be frozen.

---

Disposal Instructions

Unused or expired AllDone must not be discarded through household waste or wastewater. Official regulations require the product to be disposed of according to local regulatory requirements. Consult a pharmacist or utilize an approved drug take-back program for proper handling of medicinal waste.